This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

Un nuevo fármaco podría cambiar la forma de tratar el cáncer

Get in touch

Avatar

Get in touch

Avatar

Los resultados del primer ensayo clínico en humanos del fármaco Omomyc, un nuevo medicamento contra el cáncer, han demostrado que tiene pocos efectos secundarios y es tolerable. Además, en algunos de los pacientes, se consigue estabilizar la enfermedad.

La Dra. Elena Garralda, directora de la Unidad de Investigación de Terapia Molecular del Cáncer (UITM) - CaixaResearch del VHIO, presentó los primeros resultados de este ensayo clínico en el 34º congreso EORTC-NCI-AACR (ENA), una de las citas más importantes a nivel mundial, celebrado en Barcelona del 26 al 28 de octubre.
www.eleconomista.es/...
featured image

Tags

spain, cancer, r&d, diseases, medicine, pharma, drug, medication, research

Get in touch

Avatar

Get in touch

Avatar

Latest Insights

Creating, sharing and inspiring change. For good.

The global issues we face are challenging and interconnected. They can seem insurmountable. But if you know where to look, co-operation, positive change and hope are all around us. Build Back Ever Better is a project that recognises the progress being made, and the amazing people who are making a difference. Share your own hopes, pledges and projects with #BBEB, or become a contributor.

Please read our BBEB Charter PDF.

Join the conversation

If you have your own stories to share, please provide us with your details below to receive an invitation to start publishing your content.